Protocolo de seguimiento del tratamiento inmunosupresor en pacientes con enfermedades autoinmunes
- Bohórquez Heras, Cristina
- Movasat, A.
- Cuende Quintana, Eduardo
- Pérez Gómez, A.
ISSN: 0304-5412
Argitalpen urtea: 2013
Zenbakien izenburua: Enfermedades del sistema inmune (VI): vasculitis y miopatías inflamatorias
Saila: 11
Zenbakia: 33
Orrialdeak: 2056-2060
Mota: Artikulua
Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado
Garapen Iraunkorreko Helburuak
Laburpena
Once immunosuppressive treatment regimen for a patient with a systemic autoimmune disease, one must be aware of the serious side effects that may occur, and properly monitor each drug. In this protocol were the top immunomodulatory drugs and its most important features, indicating how the proper control of them in monitoring these patients. These drugs have been divided into two major groups, the glucocorticoids, with a significant anti-inflammatory effect but also immunosuppressive and disease modifying drugs, able to change its course through mechanisms not always well known, and to produce a powerful immunosuppression. Each of them has certain peculiarities that must be known.